Ligand Pharmaceuticals Incorporated
LGND
$210.99
$3.191.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.38% | 171.21% | 17.29% | -18.45% | 16.63% |
| Total Receivables | 18.90% | 34.59% | -1.02% | 0.87% | 7.68% |
| Inventory | -23.31% | -23.17% | 5.99% | 3.54% | -15.69% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -17.19% | -82.55% | 21.83% | 273.27% | -63.72% |
| Total Current Assets | 10.39% | 113.61% | 14.10% | -6.71% | 7.17% |
|
|
|||||
| Total Current Assets | 10.39% | 113.61% | 14.10% | -6.71% | 7.17% |
| Net Property, Plant & Equipment | -34.78% | -4.71% | 10.78% | 8.47% | -61.60% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | -3.52% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | -3.52% | 0.00% |
| Total Other Intangibles | -3.47% | -6.64% | -3.20% | -3.10% | -3.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.78% | 2.95% | 3.10% | -1.35% | -4.07% |
| Total Assets | 5.68% | 55.68% | 4.77% | -3.86% | -1.37% |
|
|
|||||
| Total Accounts Payable | -11.99% | -57.14% | 59.97% | 2.54% | 11.48% |
| Total Accrued Expenses | 40.42% | 37.25% | -28.70% | -17.11% | 93.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.75% | -2.16% | 26.05% | -31.55% | 18.35% |
| Total Finance Division Other Current Liabilities | -20.73% | -87.32% | 27.74% | 518.06% | -12.23% |
| Total Other Current Liabilities | -20.73% | -87.32% | 27.74% | 518.06% | -12.23% |
| Total Current Liabilities | 22.62% | -52.82% | 10.31% | 58.12% | 49.81% |
|
|
|||||
| Total Current Liabilities | 22.62% | -52.82% | 10.31% | 58.12% | 49.81% |
| Long-Term Debt | 0.16% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.19% | -4.62% | 29.85% | -39.21% | -6.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.37% | -8.99% | 6.42% | -30.29% | -17.29% |
| Total Liabilities | 3.19% | 338.56% | 9.26% | -1.29% | -2.07% |
|
|
|||||
| Common Stock & APIC | 10.49% | 1.11% | 5.31% | 0.94% | 9.06% |
| Retained Earnings | 5.17% | 25.32% | 1.06% | -8.51% | -5.86% |
| Treasury Stock & Other | -9.30% | 9.75% | 643.44% | 73.70% | -440.32% |
| Total Common Equity | 7.06% | 14.68% | 4.15% | -4.20% | -1.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.06% | 14.68% | 4.15% | -4.20% | -1.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.06% | 14.68% | 4.15% | -4.20% | -1.28% |
|
|
|||||